Extreme biological events: Medical experts react to DHS Sec. Chertoff's major speech
Recently, the secretary of homeland security devoted a major speech
to the challenge posed by an extreme biological event in the United
States. On this edition, co-hosts Randy Larsen and Dave McIntyre devote the entire hour as some of the
nation's leading experts analyze key aspects of that speech.:
- Anthrax: Where's the vaccine the experts say we need?
- Providing leadership during a bio-attack
- Quarantine vs. isolation: What's the difference?
- How do you quarantine 500,000 people in a city of 2 million?
- Who takes the lead when a bio-event strikes a major U.S. city?
- Advice for families: Preparing for a major bio-event
Tuesday, May 13, 7 p.m. CDT (KAMU 90.9 FM, College Station)
Subscribe to the weekly podcast:
1. Outside the Beltway, Take One
Anthrax is the most likely bio-weapon of choice among our enemies, the
experts say. So why doesn't the U.S. have an adequate supply of anthrax
vaccine? We get an analysis from immunologist Gigi Kwik Gronvall,
a senior associate at the Center for Biosecurity at University of
Pittsburgh Medical Center and an assistant professor of medicine at the
University of Pittsburgh. She also explores the question, "Are
scientific papers giving ammunition to bioterrorists?"
2. Outside the Beltway, Take Two
Say you're the mayor of a small city, and you find out that letters containing anthrax have turned up in your local post office. What do you do? It happened to Glen Gilmore, who was mayor of Hamilton, N.J., during the anthrax crisis of October 2001. His leadership during the crisis was profiled in the New York Times, the Washington Post and Time magazine. In this interview, Gilmore explains how his township reacted to the event, and his surprise at the federal and state governments' nonchalance. "If we hadn't set up a clinic on our own," he says, "it's likely more people would have died."
3. Spotlight
What is the difference between quarantine and isolation? It's a crucial
distinction during a pandemic. We get precise definitions on these and
other critical terms from Jennifer Nuzzo, senior analyst at the Center for Biosecurity at the University of Pittsburgh Medical Center. A public health professional by training, Nuzzo’s research focuses on disease mitigation strategies for pandemic
influenza as well as issues related to water security, international
preparedness, mass critical care and hospital preparedness.
4. Perspectives
How effective is quarantine during a potential pandemic? We ask Peter MacIntyre,
manager of special projects for Toronto Emergency Medical Services, who
was the city's manager community safeguards during the 2003 SARS
outbreak. He and his family also experienced quarantine during the
crisis. "It's very difficult to quarantine half a million people in a
city of 2 million," he says. "The logistics of it don't work."

5. Homeland Security at Home, Take One
If there was a bioattack in a major U.S. city like Baltimore, who would take the lead? We ask that of Brooke Courtney, an associate at the Center for Biosecurity at UPMC and former director of public health preparedness and response for the city of Baltimore's health department. Her research at UPMC focuses on altered standards of care, hospital preparedness, medical countermeasures dispensing, and public-private partnerships.
6. Homeland Security at Home, Take Two
What steps can families take to prepare for bio-events that overwhelm a community's health services? We get answers from Dr. Ann Norwood, a senior associate at the Center for Biosecurity at UPMC. She joined the center after serving as a Senior
Policy Analyst in the Office of Preparedness and Emergency Operations,
Office of the Assistant Secretary for Preparedness and Response at the
U.S. Department of Health and Human Services.















